Company expands worldwide footprint to China, Hong Kong, India, Singapore, South Korea and Taiwan for sales, distribution, and support of enzymatic synthesis products DNA Script, a world leader in
Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era in healthcare DNA Script, a leader in Enzymatic
Company to Present Monday, January 10, 2022, at 2 p.m. EST DNA Script, a leader in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced that its CEO and co-founder Thomas Ybert
Accounts and funds advised by T. Rowe Price Associates, Inc. andBaillie Gifford join syndicate of investors Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology DNA